Reliability and validity of the university of california, los angeles scleroderma clinical trial consortium gastrointestinal tract instrument

Arthritis Care and Research

Volumn 61, Issue 9, 2009, Pages 1257-1263

  Khanna, Dinesh ^a,f   Hays, Ron D ^a,b   Maranian, Paul ^a   Seibold, James R ^c   Impens, Ann ^c   Mayes, Maureen D ^d   Clements, Philip J ^a   Getzug, Terri ^a   Fathi, Nihal ^e   Bechtel, Amber ^a   Furst, Daniel E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RAND CORPORATION   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e ASSIUT UNIVERSITY   (Egypt)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOATING; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DISEASE SEVERITY; EVALUATION; FECES INCONTINENCE; FEMALE; HUMAN; INTERNAL CONSISTENCY; INTESTINE DISTENSION; MAJOR CLINICAL STUDY; MALE; PSYCHOMETRY; SCLERODERMA; SELF CONCEPT; SHORT FORM 36; SOCIAL INTERACTION; TEST RETEST RELIABILITY; UNIVERSITY OF CALIFORNIA, LOS ANGELES SCLERODERMA CLINICAL TRIAL CONSORTIUM GIT 2.0; WELLBEING;

ADULT; CONSTIPATION; DIARRHEA; FECAL INCONTINENCE; FEMALE; GASTROINTESTINAL TRACT; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX;

EID: 69749083926     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.24730     Document Type: Article

References (22)

1. Sjogren RW. Gastrointestinal motility disorders in scleroderma [review]. Arthritis Rheum 1994;37:1265-1282 (Pubitemid 24320743)
2. Lock G, Holstege A, Lang B, Scholmerich J. Gastrointestinal manifestations of progressive systemic sclerosis. Am J Gastroenterol 1997;92:763-771 (Pubitemid 27200787)
3. Nietert PJ, Mitchell HC, Bolster MB, Curran MY, Tilley BC, Silver RM. Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. J Rheumatol 2005;32:51-57
4. Gliddon AE, Dore CJ, Maddison PJ, and the Quins Trial Study Group. Influence of clinical features on the health status of patients with limited cutaneous systemic sclerosis. Arthritis Rheum 2006;55:473-479
5. Khanna D, Hays RD, Park GS, Braun-Moscovici Y, Mayes MD, McNearney TA, et al. Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument. Arthritis Rheum 2007;57:1280-1286 (Pubitemid 47585475)
6. Trezza M, Krogh K, Egekvist H, Bjerring P, Laurberg S. Bowel problems in patients with systemic sclerosis. Scand J Gastroenterol 1999;34:409-413 (Pubitemid 29232377)
7. US Food and Drug Administration. Guidance for industry: patient-reported outcome measures. Use in medical product development to support labeling claims. Rockville (MD): US Health and Human Services; 2006.
8. Ware J, Kosinski M, Dewey J. How to score version two of the SF-36 health survey. Lincoln (RI): QualityMetric; 2000.
9. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483
10. Hadorn DC, Hays RD. Multitrait-multimethod analysis of health-related quality-of-life measures. Med Care 1991;29: 829-840
11. Cronbach L. Coefficient α and the internal structure of tests. Psychometrica 1951;16:297-334.
12. Hays RD. Reliability and validity (including responsiveness). In: Fayers P, Hays RD, editors. Assessing quality of life in clinical trials. 2nd ed. New York: Oxford; 2005. p. 25-39.
13. Cohen J, Cohen P, West SG, Aiken LS. Applied multiple regression/correlation analysis for the behavioral sciences. 2nd ed. Hillsdale (NJ): Lawrence Erlbaum; 2003.
14. Joliffe IT, Morgan BJ. Principal component analysis and exploratory factor analysis. Stat Methods Med Res 1992;1:69-95.
15. Shaw M, Talley NJ, Adlis S, Beebe T, Tomshine P, Healey M. Development of a digestive health status instrument: tests of scaling assumptions, structure and reliability in a primary care population. Aliment Pharmacol Ther 1998;12:1067-1078 (Pubitemid 28508720)
16. Floyd F, Widaman K. Factor analysis in the development and refinement of clinical assessment instruments. Psychol Assess 1995;7:286-299
17. Kenefick NJ, Vaizey CJ, Nicholls RJ, Cohen R, Kamm MA. Sacral nerve stimulation for faecal incontinence due to systemic sclerosis. Gut 2002;51:881-883 (Pubitemid 35408613)
18. Sjogren RW. Gastrointestinal features of scleroderma. Curr Opin Rheumatol 1996;8:569-575
19. Khanna D. Gastrointestinal involvement in systemic sclerosis. In: Font J, Ramos-Casals M, Rodes J, editors. Digestive involvement in systemic autoimmune diseases. Amsterdam: Elsevier; 2008. p. 51-69.
20. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-145
21. Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-1285
22. Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 2005;23(5 Suppl 39):S100-8. (Pubitemid 46657517)